In summary, our data suggested that Ct-HBx downregulated the expression of TXNIP by transactivation through the transcription repressor NFATC2, then TXNIP exerted its tumor-suppressing function in HBV-induced HCC by negative regulating glycolytic metabolism (Fig. 7D). The gene discussed is NFATC2; the disease is hepatocellular carcinoma.